Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;36(6):645-652.
doi: 10.14670/HH-18-329. Epub 2021 Mar 18.

VEGF-A/VEGF-B/VEGF-C expressions in non-hereditary, non-metastatic phaeochromocytoma

Affiliations

VEGF-A/VEGF-B/VEGF-C expressions in non-hereditary, non-metastatic phaeochromocytoma

Ichiro Abe et al. Histol Histopathol. 2021 Jun.

Abstract

Vascular endothelial growth factor (VEGF) is important in pathogenesis of different cancers. The aim of this study is to investigate the relationships between different VEGFs and clinicopathological factors in patients with phaeochromocytomas. Twenty patients (10 men; 10 women) with non-hereditary, non-metastatic phaeochromocytomas were examined for VEGF mRNA expressions by polymerase chain reaction. The expressions were correlated with the clinical and pathological factors of the patients. In addition, mouse double minute 2 (MDM2) expression in these tumours were studied by immunohistochemistry. High expressions of VEGF-A, VEGF-B, and VEGF-C mRNA were detected in 11 (55%), 9 (45%), and 9 (45%) of the tumours respectively. High expression of VEGF-A in phaeochromocytomas was significantly correlated with the tumour size (p=0.025) but did not correlate with patients' age, gender, and tumour laterality. Besides, there was a trend of VEGF-A expression correlated with MDM2 expression (p=0.064). On the other hand, expressions of VEGF-B and VEGF-C were not significantly correlated with tumour size, patients' age, gender, tumour laterality, and MDM2 expression. In addition, high expressions of VEGF-B and VEGF-A were associated with increase of tumour size (p=0.042). Co-expression of different VEGFs did not correlate with MDM2 expression. To conclude, there is a role for VEGF-A/VEGF-B/VEGF-C in the pathogenesis of non-hereditary, non-metastatic phaeochromocytomas.

PubMed Disclaimer

References

    1. Abe I., Fujii H., Ohishi H, Sugimoto K., Minezaki M., Nakagawa M., Takahara S., Kudo T., Abe M., Ohe K., Yanase T. and Kobayashi K. (2019). Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma. Endocr. J. 66, 187-192. - PubMed
    1. Abe I., Nomura M., Watanabe M., Shimada S., Kohno M., Matsuda Y., Adachi M., Kawate H., Ohnaka K. and Takayanagi R. (2012). Pheochromocytoma crisis caused by Campylobacter fetus. Int. J. Urol. 19, 465-467. - PubMed
    1. Albrecht I., Kopfstein L., Strittmatter K., Schomber T., Falkevall A., Hagberg C.E., Lorentz P., Jeltsch M., Alitalo K., Eriksson U., Christofori G. and Pietras K. (2010). Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis. PLoS One 5, e14109. - PMC - PubMed
    1. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z. and Hanahan D. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell. Biol. 2, 737-744. - PMC - PubMed
    1. Bradbury R., Jiang W.G. and Cui Y.X. (2015). The clinical and therapeutic uses of MDM2 and PSMA and their potential interaction in aggressive cancers. Biomark Med. 9, 1353-1370. - PubMed

MeSH terms

Substances